Skip to content
Disclosery

EXANE DERIVATIVES: COP position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on COP, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5,114 COP shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5,114 shares
    Change vs previous 13F -7,945 shares

    0.26% of the 13F portfolio, value $459,240.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13,059 shares
    Change vs previous 13F -3,978 shares

    0.37% of the 13F portfolio, value $1,305,909.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 17,037 shares
    Change vs previous 13F +17,037 shares

    0.3% of the 13F portfolio, value $1,229,770.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-03-31
    13F 0 shares
    Change vs previous 13F -7,259 shares

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2020-12-31
    13F 7,259 shares
    Change vs previous 13F -4,617 shares

    0.09% of the 13F portfolio, value $290,300.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-09-30
    13F/A 11,876 shares
    Change vs previous 13F not available

    0.13% of the 13F portfolio, value $390,018.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).